Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

The book is a comprehensive resource on hair disorders, but lacks information on some conditions.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Topical minoxidil showed promise for early male pattern baldness.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

Extracts improve hair growth in alopecia.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Dermatologists prefer minoxidil for mild female hair loss and a combination of PRP and minoxidil for severe cases, with a need for universal treatment guidelines.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.